Bone marrow–specific Cap gene deletion protects against high-fat diet–induced insulin resistance

Author:  ["Lisa A Lesniewski","Sarah E Hosch","Jaap G Neels","Carl de Luca","Mohammad Pashmforoush","Carey N Lumeng","Shian-Huey Chiang","Miriam Scadeng","Alan R Saltiel","Jerrold M Olefsky"]

Publication:  Nature Medicine

CITE.CC academic search helps you expand the influence of your papers.

Tags:     Medicine

Abstract

Cbl-associated protein (Cap) is a member of a phosphatidylinositol 3-kinase–independent pathway for insulin-stimulated translocation of the glucose transporter GLUT4. Despite this positive role of Cap in glucose uptake, here we show that deletion of the gene encoding Cap (official gene name: Sorbs1) protects against high-fat diet (HFD)–induced insulin resistance in mice while also having an opposite, insulin-sensitizing effect, accompanied by reduced tissue markers of inflammation. Given the emerging role of chronic inflammation in insulin resistance and the macrophage in initiating this inflammatory process, we considered that Sorbs1 deletion from macrophages may have resulted in the observed protection from HFD-induced insulin resistance. Using bone marrow transplantation to generate functional Sorbs1-null macrophages, we show that the insulin-sensitive phenotype can be transferred to wild-type mice by transplantation of Sorbs1-null bone marrow. These studies show that macrophages are an important cell type in the induction of insulin resistance and that Cap has a modulatory role in this function.

Cite this article

Lesniewski, L., Hosch, S., Neels, J. et al. Bone marrow–specific Cap gene deletion protects against high-fat diet–induced insulin resistance. Nat Med 13, 455–462 (2007). https://doi.org/10.1038/nm1550

View full text

>> Full Text:   Bone marrow–specific Cap gene deletion protects against high-fat diet–induced insulin resistance

Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes

Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease